Sarilumab
| Monoclonal antibody | |
|---|---|
| Type | Whole antibody |
| Source | Human |
| Target | IL-6 |
| Clinical data | |
| Legal status |
|
| Routes of administration |
Subcutaneous injection |
| Identifiers | |
| CAS Number | 1189541-98-7  |
| ATC code | none |
| KEGG | D10161 |
| Chemical data | |
| Formula | C6388H9918N1718O1998S44 |
| Molecular mass | 144.13 kg/mol |
 (what is this?) (verify) |
|
Sarilumab is a human monoclonal antibody against the interleukin-6 receptor.[1]
Regeneron and Sanofi are currently co-developing the drug for the treatment of rheumatoid arthritis (RA), for which it is in phase III trials.
Development in ankylosing spondylitis has been suspended after the drug failed to show clinical benefit over methotrexate in a phase II trial.[2]
Clinical trials
On May 15, 2013, both companies announced that 2 new trials were starting (COMPARE and ASCERTAIN) and the first patients had already been enrolled.[3]
In June 2015 a phase 3 trial (with methotrexate) for RA reported meeting its 3 coprimary endpoints.[4]
In Nov 2015 the SARIL-RA-TARGET trial reported good results (meeting both its coprimary end points).[5]
See also
- Anti-IL-6 anti-inflammatories
References
- ↑ Lua error in package.lua at line 80: module 'strict' not found. Needs subscription
- ↑ Sanofi and Regeneron Report Positive Phase 2b Trial Results with Sarilumab in Rheumatoid Arthritis. July 2011
- ↑ Sanofi and Regeneron Announce Patient Enrollment in Two Phase 3 Trials with Sarilumab in Rheumatoid Arthritis (RA). May 2013
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Sarilumab effective in broad range of RA patients: Study
<templatestyles src="Asbox/styles.css"></templatestyles>
 |
This monoclonal antibody-related article is a stub. You can help Wikipedia by expanding it. |
<templatestyles src="Asbox/styles.css"></templatestyles>
 |
This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it. |
- Chemical articles having calculated molecular weight overwritten
- Drugs that are a monoclonal antibody
- Articles without EBI source
- Chemicals that do not have a ChemSpider ID assigned
- Chemical pages without DrugBank identifier
- Articles without InChI source
- Articles without UNII source
- Drugs not assigned an ATC code
- Monoclonal antibodies
- Monoclonal antibody stubs
- Antineoplastic and immunomodulating drug stubs
